SciELO - Scientific Electronic Library Online

 
vol.23 número2Refining of buriti oil (Mauritia flexuosa) originated from the Brazilian Cerrado: physicochemical, thermal-oxidative and nutritional implicationsDichloroiodoisocyanuric acid: a new reagent for regioselective coiodination of alkenes and iodination of activated arenes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Journal of the Brazilian Chemical Society

versión impresa ISSN 0103-5053

Resumen

HONORATO, Sara B. et al. Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests. J. Braz. Chem. Soc. [online]. 2012, vol.23, n.2, pp. 220-227. ISSN 0103-5053.  http://dx.doi.org/10.1590/S0103-50532012000200005.

This study evaluates the incidence of the polymorphic forms of mebendazole (MBZ) in tablets within the Brazilian market by dissolution tests. The indicated dissolution medium by the USP 30 (United States Pharmacopoeia) and a proposed modified medium were duly compared in order to verify whether they are able to discriminate the polymorph A from polymorph C in commercial tablets. Dissolution assay tests of physical mixtures in raw materials of polymorph A and polymorph C, as well as of nine tablets of MBZ (available in the Brazilian market), were properly performed. For the dissolution tests, the USP 30 medium (I) and a modified medium (II) were used. The modified medium allowed a reproducible and reliable quality control of MBZ polymorphism in commercial tablets.

Palabras llave : mebendazole; polymorphism; solubility; Raman spectroscopy; X-ray powder diffraction.

        · resumen en Portugués     · texto en Inglés     · pdf en Inglés